Fissen Technology completed the hundreds of millions of yuan C round of financing led by Sequoia China

Domestic digital oral industry leader, digital oral overall solutions provider - Shenzhen Feisen Technology Co., Ltd. (hereinafter referred to as "Fison Technology") recently announced the completion of hundreds of millions of yuan C round of financing, this round of financing by Sequoia Capital China Fund, CNOOC Capital's fund, Kaiyuan Guo venture, the former jellyfish fund, Ping An Ventures and other new and old shareholders followed by investment.

Capital acted as an exclusive financial advisor to Fison Technologies in this transaction.The success of this financing highlights the domestic first-line star fund with an international perspective of the domestic digital dental leading enterprises fully recognized, but also highlighted The strong position of Yikai Capital in the field of digital medical investment and financing.Fissen Technology was founded in 2010 to oral digital imaging equipment and SaaS system and other digital hardware and software as the entrance, to create oral digital platform, connect the industry's upstream and downstream resources, provide oral high-value data value-added services, build oral 3D design platform, and finally achieve oral end products (planting, orthodontic, digital aesthetic repair, etc.) solutions full coverage, to build the industry-leading digital oral new ecology.At present, The three core businesses of Fessen Technology are in the leading position in the industry: oral digital imaging equipment sales network covers 29 provinces and cities nationwide, the number of contracted agents close to 100, and actively carry out the layout of overseas sales network; Active clinic users, in the sub-sector oral specialist hospital share of more than 50%, oral large chain share of more than 30%, small and medium-sized outpatient market and other dimensions of the possession, share, high frequency active user volume and other core indicators of the industry far ahead;"The oral industry is the fastest growing specialized sector in China, with an annual growth rate of more than 20%, and the national oral medical equipment and related products and services market is expected to exceed 400 billion yuan by 2020," said Fissen Technology. But at present, the oral industry as a whole still presents the characteristics of scattered, the pain point is outstanding: the pain point of the circulation link of the industry is concentrated in low concentration, many suppliers, the product is uneven, the pain point of the terminal clinic is concentrated in small scale, scattered, internal management confusion, high customer turnover rate, the pain point of the overall service project is high dependence on doctors, high doctor cost, low digital level. We are from the industry's most profound pain point, through digital upgrading supply chain and terminal clinic services and management capabilities, to achieve the industrial chain upstream and downstream docking, in the next two years, we will accelerate the construction of digital design platform, to achieve immediate communication between doctors and patients, digital empowerment design and manufacturing links, to build digital terminal products industry chain, accelerate the pace of digital oral ecosystem construction.about the investment, Sequoia Capital China Fund partner Zhou Wei said: "The company has a platform, brand, resources and other aspects of the advantages of far superior to the opponent, the founding team has a wealth of industry experience and action of the industry vision." With the company's continuous layout of imaging equipment, dental butler platforms, supply chains, and end clinics, we are optimistic about the new ecology of the oral industry chain built by Fessen in the digital age, and we are more optimistic that the company will become an industry leader and an aggregator of industry value.as an investment banking consultant for the transaction, Yikai Capital partner Li Gang said: "China's oral medicine market size of more than 100 billion, and Fissen Technology is one of the few companies in China that can open up the industry upstream and downstream, to achieve full process management, industry synergy." In just a few years, the company realized the collaborative development of hardware and software, and constantly broaden the boundaries, the use of digital empowerment of the entire industrial chain. In the future, the company will continue to extend to consumer products and solutions, and we very much agree with the company's vision and strategic layout. Ike Capital is proud to be able to help Fison Technologies complete this financing and is confident that the company will grow into a global leader in the oral industry in the long term. Asnew investor in the current round of financing, the FUND Capital Project Team said that the oral cavity is one of the areas with high degree of marketization, market potential and rapid technology iteration in the domestic medical industry. Fissen Technology to software services as the entrance, has now formed three major business sectors of imaging, SAAS and oral supply chain, is gradually realizing the integration of the entire industrial chain. ZHONGC Capital has long been optimistic about the market potential of the domestic oral field under the digital background and the competitive barriers that the company has formed.

After this round of financing, Fissen Technology will accelerate the acquisition of upstream and downstream industrial resources, the development of digital design platform, and accelerate the coverage from oral digital hardware and software facilities to consumer end-product solutions, and finally realize the ecological layout of the entire industrial chain.About Sequoia Capital China FundSequoia Capital is committed to helping entrepreneurs achieve the foundation of evergreen great companies, bringing member companies a wealth of global resources and valuable historical experience. For 48 years, Sequoia Capital has invested in many innovative companies and industry trends. Sequoia Capital China Fund, as the "entrepreneur behind entrepreneurs", focuses on investment opportunities in the four directions of technology/media, healthcare, consumer goods/modern services, and industrial technology. Over the past 15 years, Sequoia Capital China Has invested in nearly 600 companies with distinctive technical characteristics, innovative business models, high growth and development potential.About Yikai Capitalis a leader in China's new economic investment bank, focusing on the global TMT, consumer and health industries. Outside the investment banking business, Yikai Capital is managing a renminbi fund and a dollar fund. The company has branches in Beijing, Shanghai, Los Angeles and San Francisco and holds U.S. securities market licenses. The health industry is an area that Yikai Capital focuses on and has deep advantages in, and its rich trading experience and team of high-quality talents in the industry have determined that Yikai has a deep understanding and insight into the health industry and its investment logic.
(
arterial network)